Photodynamic therapy-induced death of MCF-7 human breast cancer cells: A role for caspase-3 in the late steps of apoptosis but not for the critical lethal event

Experimental Cell Research

Volumn 263, Issue 1, 2001, Pages 145-155

  Xue, L Y ^a   Chiu, S M ^a   Oleinick, N L ^a  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Apoptosis; Caspase; Clonogenicity; Pc 4; Photodynamic therapy

Indexed keywords

CASPASE 3; CYTOCHROME C; DNA FRAGMENT; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; PC 4; PHTHALOCYANINE; TETRAZOLIUM;

APOPTOSIS; ARTICLE; BREAST CANCER; CELL STRAIN MCF 7; CELL VIABILITY; CHROMATIN CONDENSATION; CLONOGENESIS; CONTROLLED STUDY; DNA STRAND BREAKAGE; ENZYME ACTIVATION; ENZYME RELEASE; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; LETHALITY; LIGHT; MITOCHONDRION; PHOTODYNAMIC THERAPY; PHOTOSENSITIZATION; PRIORITY JOURNAL; PROTEIN DEGRADATION; SIGNAL TRANSDUCTION;

MINK CELL FOCUS-FORMING VIRUS;

EID: 0035242501     PISSN: 00144827     EISSN: None     Source Type: Journal    
DOI: 10.1006/excr.2000.5108     Document Type: Article

References (60)

1. Caspases: The executioners of apoptosis
2. Caspase-3 is required for DNA fragmentation and morphological changes associated with apoptosis
3. Cleavage of DFF-45/ICAD by multiple caspases is essential for its function during apoptosis
4. Cell-specific induction of apoptosis by microinjection of cytochrome c
5. Caspase-3-dependent cleavage of Bcl-2 promotes release of cytochrome c
6. Caspase-3 is required for alpha-fodrin cleavage but dispensable for cleavage of other death substrates in apoptosis
7. Caspase-3 is necessary and sufficient for cleavage of protein synthesis eukaryotic initiation factor 4G during apoptosis
8. DFF, a heterodimeric protein that functions downstream of caspase-3 to trigger DNA fragmentation during apoptosis
9. Cleavage of CAD inhibitor in CAD activation and DNA degradation during apoptosis
10. The 40-kDa subunit of DNA fragmentation factor induces DNA fragmentation and chromatin condensation during apoptosis
11. Caspase-3-generated fragment of gelsolin: Effector of morphological change in apoptosis
12. Apoptosis induced by vitamin D compounds in breast cancer cells is inhibited by Bcl-2 but does not involve known caspases or p53
13. Cleavage of automodified poly(ADP-ribose) polymerase during apoptosis. Evidence for involvement of caspase-7
14. Initiation of growth arrest and apoptosis of MCF-7 mammary carcinoma cells by tributyrin, a triglyceride analogue of the short-chain fatty acid butyrate, is associated with mitochondrial activity
15. Activation of a cysteine protease in MCF-7 and T47D breast cancer cells during beta-lapachone-mediated apoptosis
16. Differences in susceptibility to tumor necrosis factor alpha-induced apoptosis among MCF-7 breast cancer cell variants
17. Photodynamic therapy induces rapid cell death by apoptosis in L5178Y mouse lymphoma cells
18. How does photodynamic therapy work?
19. Photochemotherapy of cancer: Experimental research
20. Correlation of subcellular and intratumoral photosensitizer localization with ultrastructural features after photodynamic therapy
21. Initiation of apoptosis versus necrosis by photodynamic therapy with chloroaluminum phthalocyanine
22. Protease activation and cleavage of poly(ADP-ribose) polymerase: An integral part of apoptosis in response to photodynamic treatment
23. The photobiology of photodynamic therapy: Cellular targets and mechanisms
24. Ceramide generation in response to photodynamic treatment of L5178Y mouse lymphoma cells
25. Rapid tyrosine phosphorylation of HS1 in the response of mouse lymphoma L5178Y-R cells to photodynamic treatment sensitized by the phthalocyanine Pc 4
26. Promotion of photodynamic therapy-induced apoptosis by stress kinases
27. The induction of partial resistance to photodynamic therapy by the protooncogene BCL-2
28. Association of ceramide accumulation with photodynamic treatment-induced cell death
29. Etk/Bmx, a PH-domain containing tyrosine kinase, protects prostate cancer cells from apoptosis induced by photodynamic therapy or thapsigargin
30. Photodynamic therapy-induced apoptosis in lymphoma cells: Translocation of cytochrome c causes inhibition of respiration as well as caspase activation
31. Stress-activated signalling responses leading to apoptosis following photodynamic therapy
32. Rapid cytochrome c release, activation of caspases 3, 6, 7 and 8 followed by Bap31 cleavage in HeLa cells treated with photodynamic therapy
33. Photodynamic therapy: A mitochondrial inducer of apoptosis
34. The activation of the c-Jun N-terminal kinase and p38 mitogen-activated protein kinase signaling pathways protects HeLa cells from apoptosis following photodynamic therapy with hypericin
35. Caspase-8 mediates caspase-3 activation and cytochrome c release during singlet oxygen-induced apoptosis of HL-60 cells
36. Nuclear factor-kappaB activation by the photochemotherapeutic agent verteporfin
37. Effects of BAPTA-AM and forskolin on apoptosis and cytochrome c release in photosensitized Chinese hamster V79 cells
38. Detection of the initial stages of DNA fragmentation in apoptosis
39. Specific proteolytic cleavage of poly(ADP-ribose) polymerase: An early marker of chemotherapy-induced apoptosis
40. Cleavage of poly(ADP-ribose) polymerase by a proteinase with properties like ICE
41. Caspase-3 is essential for procaspase-9 processing and cisplatin-induced apoptosis of MCF-7 breast cancer cells
42. Role of caspases in immunotoxin-induced apoptosis of cancer cells
43. Nitric oxide suppression of apoptosis occurs in association with an inhibition of Bcl-2 cleavage and cytochrome c release
44. Induction of apoptosis in MCF-7:WS8 breast cancer cells by beta-lapachone
45. Caspase-3 controls both cytoplasmic and nuclear events associated with Fas-mediated apoptosis in vivo
46. Condensed matter in cell death
47. Caspase activation involves the formation of the aposome, a large (approximately 700 kDa) caspase-activating complex
48. Autoactivation of procaspase-9 by Apaf-1-mediated oligomerization
49. Inhibition of Ced-3/ICE-related proteases does not prevent cell death induced by oncogenes, DNA damage, or the Bcl-2 homologue Bak
50. BAX-induced cell death may not require interleukin 1 beta-converting enzyme-like proteases
51. Anti-apoptotic oncogenes prevent caspase-dependent and independent commitment for cell death
52. Commitment to cell death measured by loss of clonogenicity is separable from the appearance of apoptotic markers
53. The point of no return: Mitochondria, caspases, and the commitment to cell death
54. The mitochondrial death/life regulator in apoptosis and necrosis
55. Mitochondrial release of caspase-2 and -9 during the apoptotic process
56. Mitochondria and apoptosis
57. Mitochondrial control of apoptosis
58. RGD peptides induce apoptosis by direct caspase-3 activation
59. Apoptosis, p53, and tumor cell sensitivity to anticancer agents
60. Heterogeneity in the development of apoptosis in irradiated murine tumours of different histologies